Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Naunyn Schmiedebergs Arch Pharmacol ; 391(1): 27-36, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29067514

ABSTRACT

Estrogenic compounds have been documented in literature to exert neuroprotective effects. This study investigated the potential neuroprotective effect of genistein; a phytoestrogen at doses of 5, 10, 20, and 40 mg/kg p.o. in ovariectomized rats challenged with pentylenetetrazole (PTZ) 90 mg/kg i.p. Systemic acute administration of PTZ induced seizures, increased oxidative stress, and caused apoptosis and histological abnormalities. Pretreatment with genistein delayed seizure onset, reduced the seizure duration, improved oxidative stress profile, decreased estrogen receptor expression, reduced apoptosis, and improved the histopathological pattern. Overall, the genistein doses (10 and 20 mg/kg) showed the strongest protective effects. In conclusion, the current study suggests that genistein exhibits neuroprotective effects against PTZ-induced seizures. Such effects might be attributed to its estrogenic, antioxidant, and/or anti-apoptotic properties.


Subject(s)
Brain Chemistry/drug effects , Genistein/therapeutic use , Ovariectomy/adverse effects , Pentylenetetrazole/toxicity , Seizures/drug therapy , Seizures/metabolism , Animals , Brain/drug effects , Brain/metabolism , Brain/pathology , Brain Chemistry/physiology , Dose-Response Relationship, Drug , Female , Genistein/pharmacology , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Ovariectomy/trends , Phytoestrogens/pharmacology , Phytoestrogens/therapeutic use , Rats , Rats, Wistar , Seizures/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...